


A growing income and long-term capital growth by investing nearly two thirds in UK equities and the rest in UK investment grade corporate bonds and gilts.
| Name | % Net Assets |
|---|---|
| UK Treas 2.500 Apr 16 20 I/L | 9.8% |
| UK Treas 2.500 Jul 26 16 I/L | 7.6% |
| Glaxosmithkline | 4.0% |
| Royal Dutch Shell | 3.7% |
| BP | 3.5% |
| HSBC Holdings | 2.9% |
| Vodafone | 2.9% |
| Unilever | 2.3% |
| ASTRAZENECA | 2.1% |
| Signet Jewelers | 1.7% |
| Key | % Net Assets |
|---|---|
| 9.8% | |
| 7.6% | |
| 4.0% | |
| 3.7% | |
| 74.9% |
| Date | 20-Aug-2025 |
|---|---|
| Bid | 244.99p |
| Offer | 244.99p |
| Currency | GBP |
| Change | 0.46p |
| % | 0.19% |
| YTD change | 18.47p |
| YTD % | 8.15% |
| Fund Inception | 23/05/2005 |
|---|---|
| Fund Manager | n/a |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research